肝血管瘤CT动脉期分型对介入治疗的临床应用
|
摘要
目的评价双源64排螺旋CT三期增强扫描及3D后处理重建对肝脏血管瘤容积测定的诊断价值;动脉期强化的分组分型对临床的应用价值。方法回顾性分析300例肝血管瘤的CT资料;所有病例均应用SIEMENS双源64排螺旋CT进行三期动态增强扫描,全部测定了患者的不同时相的CT值。其中有185例根据瘤体最大直径(d)分成三组(4cm10cm及d<4cm三组),应用容积测定软件测定不同时相的强化容积,进行分型。结果①300例病例中,共有452个病灶,有415个病灶(91.82%)在平扫时为低密度,37个(8.18%)病灶为等或高密度;动脉期385个病灶边缘点状、斑片状强化,67个未出现强化;门脉期及延迟期相继出行强化,最终都强化至等密度。3D后处理后,可从不同角度、不同时相肿瘤强化容积的改变看到不同的瘤体整体形态学改变及肿瘤与肝动脉之间的关系。②直径小于4cm的肝血管瘤动脉期强化比率均大于28%,平均为53.68±13.25%; 4cm10cm的肝血管瘤动脉期强化容积比率均小于18.50%,平均为13.28%±4.26%。双源64排螺旋CT三期动态增强扫描可了解肝脏血管瘤的血供情况,从而为肝脏血管瘤的动脉栓塞治疗提供依据。结论(1)双源64排螺旋CT三期增强扫描及3D后处理可清楚显示肝血管瘤的CT表现,对血管瘤的诊断及鉴别诊断有明显的优势。(2)对于4cm 目的分析介入栓塞治疗对不同类型肝血管瘤的影响及疗效评价。方法搜集32例经过动脉栓塞治疗的肝血管瘤患者,术前均行三期动态增强扫描,并测量术前的瘤体容积及动脉期强化比率;应用平阳霉素-碘乳剂行动脉栓塞治疗,术后6个月随访复查CT,测量瘤体体积,计算体积缩小率,进行统计分析评价疗效。结果全部病例经动脉栓塞治疗前后瘤体体积缩小有统计学意义;富、乏血供组间瘤体缩小率差异有统计学意义(P<0.05);4例d>10cm的血管瘤患者行动脉栓塞后瘤体容积均较术前缩小,但效果不明显,需要二次栓塞。结论1)动脉栓塞治疗直径4-10cm的肝血管瘤,不论富血供还是乏血供的患者都有很好的疗效,但是以富血供肿瘤效果更明显;2)双源64排螺旋CT评价肝血管瘤栓塞治疗后的疗效评价有很大的应用价值。
Objective Evaluation of dual-source 64-slice spiral CT 3-phase contrast-enhanced scanning and 3D post-processing of volume determination of liver hemangioma diagnosis; arterial phase enhancement the groups and types effect on the value of Clinical application.Methods 1)Retrospective analysis of clinical pathology by the 300 confirmed cases of hepatic hemangioma CT data.All cases applied for three dynamic enhanced scan and 3D-reprocessing. Determine the CT value of all cases of hepatic hemangioma in patients at different phases. 185 cases,according to the biggest diameter,we fall into 3 groups (4cm10cm、d<4cm),and using 3D software to determine enhanced capacity at different phases. Results 1)300 cases,452 lesions.In plain,91.82% of the lesions show low density lesions;8.18% lesions appear high or identical density leisons. And after enhanced scan, in the arterial phase, 92.78% of lesions appear nodular or patchy edge enhancement, 14.82% leisons have no enhancement; in the portal and the extension phase, the scope of the lesions increased gradually expanded,and the last appear epual density lesions。After 3D post-processing,in different angles and different phases,tumor volume changes that different morphological changes in the overall tumor and the relation of between liver hemangioma and liver artery。2) The diameter is less than 4.00cm of hepatic hemangioma in the arterial phase enhancement ratios are more than 28.00% with an average of 53.68±13.25%;4.0cm 10.0cm hepatic arterial vascular tumor volume ratio of enhancement was less than 18.50%,,an average of 13.28%±4.26%。Conclusions①Dual-source 64-slice spiral CT CT 3-phase contrast-enhanced scanning and 3D post-processing clearly shows the typical CT hepatic hemangioma performance,and great value of vascular diagnosis and differential diagnosis。②For 4.0cm 10.0cm hepatic hemangiomas mostly for lack of blood type。Dual-source 64-slice spiral CT three dynamic enhanced understanding of hepatic hemangioma scan the blood supply to the liver hemangioma embolization therapy。
Objective Analyze interventional treatment of liver hemangioma effect of different types。Methods Collected 32 patients of hepatic hemangioma undergo properative three dynamic contrast-enhanced scan.Measure tumor volume and ratio of arterial phase enhancement;apply the same density pingyangmycin-Iodine lotion to treat hepatic hemangioma in arterial embolization and follow-up and recheck CT after operation,measure the tumor volume,calculate the ratio of volume reducement and evaluate curative effect by statistical analysis. Results The difference of the tumor volume of all the cases before and after treatment by TAE were showed statistical significance. The difference of minification of tumor between the rich and lack blood-supply groups were showed statistical significance (P<0.05).But at d>10cm group,all 4 cases only undertake summary,effect is not very clear by arterial embolization.And for d<4cm group,because the patient choose follow-up observation. Conclusions 1)For 4cm
Objective Evaluation of dual-source 64-slice spiral CT 3-phase contrast-enhanced scanning and 3D post-processing of volume determination of liver hemangioma diagnosis; arterial phase enhancement the groups and types effect on the value of Clinical application.Methods 1)Retrospective analysis of clinical pathology by the 300 confirmed cases of hepatic hemangioma CT data.All cases applied for three dynamic enhanced scan and 3D-reprocessing. Determine the CT value of all cases of hepatic hemangioma in patients at different phases. 185 cases,according to the biggest diameter,we fall into 3 groups (4cm
Objective Analyze interventional treatment of liver hemangioma effect of different types。Methods Collected 32 patients of hepatic hemangioma undergo properative three dynamic contrast-enhanced scan.Measure tumor volume and ratio of arterial phase enhancement;apply the same density pingyangmycin-Iodine lotion to treat hepatic hemangioma in arterial embolization and follow-up and recheck CT after operation,measure the tumor volume,calculate the ratio of volume reducement and evaluate curative effect by statistical analysis. Results The difference of the tumor volume of all the cases before and after treatment by TAE were showed statistical significance. The difference of minification of tumor between the rich and lack blood-supply groups were showed statistical significance (P<0.05).But at d>10cm group,all 4 cases only undertake summary,effect is not very clear by arterial embolization.And for d<4cm group,because the patient choose follow-up observation. Conclusions 1)For 4cm
引文
[1]李果珍,王仪生,戴建平.临床CT诊断学[M].北京:中国科学技术出版社,1994:420-422.
[2] Ishak KG, Robin L Benign tumors of the liver.Med Clinivorth Am, 1975,59(4):995-1013.
[3] Tulsyan N, Kashyap VS, Greenberg RK.The endovascular management of visceral artery aneurysns and pseudoaneurysms. Vasc, 2007, 45: 276-282.
[4] Trastek VF, Van Heerden JA, Sheedy PF.Cavernous hemangiomas of the liver:resect or observe.AmJ Surg, 1983, 145(1):49-53.
[5]马飞虹,王曼曼,朱光宇. 200例肝血管瘤的CT变现探索[J].黑龙江医药科学,2006, 29(6): 80.
[6]章其林.多层螺旋CT动脉期对肝海绵状血管瘤的诊断价值[J].淮海医药, 2009, 27(5): 398-399.
[7]王捷,孙德仁.组织CT值及电子相对密度的测定及结果分析[J].中华放射肿瘤学杂志,2004,13(4):307-308.
[8]邱双健,樊嘉,陈培.肝脏血管瘤的影像学诊断[J].肝胆外科杂志,2008, 16(6):497-411.
[9]朱斌.肝血管瘤放射介入治疗[J].肝胆外科杂志,2005, 14(2):93-95.
[10] Chen JH, Shen WC. Hyperdynamic hemangioma with proximal arterioportal shunting: a rare manifestation.Eur Radiol, 2003, 13: 1920.
[11]李兴胜,王世锦,谭戈辉.肝脏转移瘤的CT表现[J].临床肝胆病杂志,2006,22(4):265-266.
[12] Jang H,Kim TK, Lim HK. Hepatic Hemangioma:Atypical Appearances on CT, MR Ima-ging, and Sonography.AJR, 2003, 180(1): 135-141.
[13]曹丹庆,蔡祖龙.全身CT诊断学[M].北京:人民军医出版社, 1996:440.
[14] Jiang Lin, Yuan Ji. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma.Original Article liver, 2010, 9(2): 154-158.
[15]李斐,陈国新.肝脏肿瘤的超声诊断及鉴别诊断[J].中国实用医药,2010, 5(11):103-104.
[16] Mortele KJ, Vanzieleghem B, Mortele B. Solitary hepatic hemangioend othelioma: dyna- mic gadolinium-enhanced MR imaging findings. European Radiology. 2002, 12: 862.
[17] Mathieu D, Bruneton JN, Drouilard J.Hepatic Adenomas and Focal Nodular Hyperplasia:Dynamic CT Study.Radiology, 1986, 160(1): 53.
[18]王俭,刘光华,肖湘生,等.肝血管瘤的临床、病理再评价[J].实用放射性杂志,1999,15(2):99-100.
[19]荣增辉.肝血管瘤的CT诊断[J].现代医药卫生,2007, 23(7):1045-1046.
[20]俞滕先,郭宏伟,刘杰.多层螺旋CT对肝血管瘤的价值[J].重庆医学,2009,(38)13: 1635-1637.
[21]欧阳墉,王颖,欧阳雪辉,等.肝血管瘤供血和介入治疗的争议和探讨[J].中华放射学杂志,2004,38(7):746-750.
[22] Cynthia H. McCollough,PhD,Andrew N.Primak,PhD,Dose Performance of a 64-Channel Dual-Source CT Scanner.Radiology 2007,243:775-784.
[23] Kate Madden Yee, Multislice CT powers up with dual-source scanning. Special Report Trend in Radiology, 2007.
[24] Kim KW,Kim TK. Hepatic hemangiomas with arterioportal shunt : findings at twoph- ase CT. Radiology,2001,219 :707.
[25]李斐,陈国新.肝脏肿瘤的超声诊断及鉴别诊断[J].中国实用医药,2010,5(11):103-104.
[26]章其林.多层螺旋CT动脉期对肝海绵状血管瘤的诊断价值[J].淮海医药,2009, 27(5):398-399.
[27] Yamashita Y, ogata I, Urata J. Cavernous hemangioma of the liver:pathologic correlation with dynamic CT findings.Radiology, 1997, 203:121-125.
[28] MoriyasuH.Hepatic hemnagioma complicated with adenomyosis of the stomach:Primay right hepatic lobectomy and gaserectomy.Shujutsu,1962,16:1062.
[29]孙中杰,王国俊,潘承恩等.肝血管瘤的供血方式[J].第四军医大学学报,2002,23(6):576.
[30]赵仲蓉,李国威,王宝太,等.肝脏巨大海绵状血管瘤碘油栓塞治疗及其血供研究[J] .中华放射学杂志,1994,28 (7) : 472-474.
[31]杜锡林,马庆久,赵析山.等. B超引导下集束电极射频热毁损治疗肝脏海绵状血管瘤[J].中国实用外科杂志,2001,21(12):725-726.
[32]曾庆乐,李彦豪,陈勇,等.平阳霉素碘油乳剂治疗肝海绵状血管瘤的临床应用[J].介入放射学杂志,2000,34(7):456-458.
[1]叶继章.经导管注入平阳霉素碘化油乳剂栓塞肝血管瘤疗效分析[J].吉林医学,2010,31(30):5333.
[2]苏彬. [肝巨大血管瘤手术策略],杭州:浙江大学,2009.
[3]郭启勇,申宝忠.介入放射学[M].北京:人民卫生出版社.2008,50.
[4]崔新建,王兆欣,陈保伦,等.血管内介入改良Seldinger技术股动脉指间定位法的研究与临床应用[J].中国医学影像技术,2001,17(2):190-191.
[5]胡跃峰.[肝血管瘤动脉栓塞疗效及其供血的分析研究],太原:山西医科大学,2006.
[6] GaoKA. Analysis of the Cause of Lipiodol Incompletely Accumulated in Liver Can- cer after TACE.Chin J Med Imaging Technol,2003,19(7):918-919.
[7] W.K.Moon,B.I.Choni,etal.Iodized-oi1 retention within hepatic hemangio ma: Charact- eristics on iodizee-oil CT.Abdom Imaging 1996,(21):420-426.
[8]邓燕贤,漆剑频.经肝动脉平阳霉素乳剂介入治疗肝海绵状血管瘤[J].放射性实践,2004,19(4):280-282.
[9]曾庆乐,李彦豪,陈勇,等.平阳霉素碘油乳剂治疗肝海绵状血管瘤的临床应用[J].介入放射学杂志,2000,34(7):456-458。
[10]廖凯兵,孙仁荣,卢雅仁.肝脏巨大海绵状血管瘤的介入治疗(附20例分析)[J].医学影像学杂志,2003,13(5):318-320.
[11]仉凤,暴玉振,等.平阳霉素碘油剂栓塞子宫动脉致肺毒性反应一例[J].介入放射学杂志,2004,13(4):350.
[12] Yamashita Y,Ogata I,Urata J. Cavernous hemangioma of the liver : pathologic correlation with dynamic CT findings. Radiology,1997,203:121.
[13]曾庆乐,李彦豪,陈勇,等.肝海绵状血管瘤的动脉造影分析[J].临床放射性杂志,2009,28(5):688-691.
[14] Zeng QL, Li YH, Chen Y. Gigantic cavernous hemangioma of the liver treated byIntra-arterial embolization with pingyangmycin-lipiodol emulsion: a multicenter study. C- ardiovasc Intervent Radiol, 2004, 27 :481-485.
[15]孙华,董永安,王苏峰,等.肝血管瘤肝动脉栓塞的疗效评价[J].生物医学工程与临床,2005,9(1):25-27.
[16] Tulsyan N,Kashyap VS,Greenberg RK.The endovascular management of visceral artery aneurysns and pseudoaneurysms. Vasc,2007,45:276-282.
[1] Hapatake J, Horie A, Nagafuchi Y . Hyalinized hemangioma 0f the liver[J].Am J Gastro- entero1. 1992, 87 (2) : 234 - 236.
[2]罗雁,陆伟.肝血管瘤的诊断与治疗[J].医学综述,2006, 12 (4) : 416.
[3]李绍林,张雪林,韩慧霞,等.周围型胆管细胞癌临床病理与CT及MR诊断研究[J].放射学实践, 2005, 20 (6) : 500.
[4] Lee VT, Magnaye M, Tan HW, Thng CH, Ooi LL. Scler osing haemangioma mimicking hepatocellular carcinoma [J]. Singapore Med J , 2005 Mar, 46 (3) : 140 - 143.
[5]谢玉茹,全显跃.周围型肝内胆管细胞癌的MR诊断价值[J].放射学实践, 2006, 21 (8) : 797 - 800.
[6]古杰洪,莫蕾,王海林,等.肝硬化性血管瘤的CT诊断与误诊分析[J].实用医学杂志, 2006, 22 (3) : 351 - 353.
[8]万亚红,张光休,程可洛.肝硬化性血管瘤7例[J].江西医药,1999:102-103.
[9]Selby DM, Stocker JT, Waclawtw MA. Infantile hemangioendothelioma of the liver[J]. Hepatology,1994,20:39-45.
[10] Diment J, Yurim O, Pappo O. Infantile hemangioendothelioma of the liver in an adult. Arch Pathol Lab Med,2001,125:931-932.
[11]徐赛英.实用儿科放射诊断学[M].北京:北京出版社,1999.629-632.
[12] Kaniklides C, Dimopoulos PA, Bajic D. Infantile hemangioendothelioma.Acta Radiolog- ic,2000,41:161-164.
[13] Schweinitz DV Management of liver tumors in children.Seminars in pediatric Surgery, 2006,15(1):17-24.
[14]胡显良,何小兵.小儿肝脏肿瘤分析与介入治疗[J].广州医药,2001,32(5): 22-23.
[15] DallerJA ,Bueno GJ ,Dvorchik I. Hepatic Hemangioendot helioma:Clinical Experience and Management Strategy.Pediatr Surg,1994,34(1):98.
[16] Davenport M , Hansen L , Heaton ND. Hemangioendot helioma of t he Liver in Infants .J Pediat r Surg ,1995 ,30 (1) :44.
[17] Prokurat A , Klug P ,Chrupek M.Hemangioma of the liver in children : preliferating vas- cular tumor or congenital vascular malformation.Med Pediatr Oncol, 2002,39 :524 - 529.
[18] Prokurat A, Kluge P, Chrupek M. Hemangioma of the Liver in Children: Proliferating Vascular Tumor or Congenital Vascular Malformation Med Pediatr Oncol , 2002, 39( 5) : 524- 529.
[19] Kassarjian A, Zurakowski D, Dubois J. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR, 2004, 182( 3) : 785- 795.
[20] Buonomo C, Taylor GA, Share JC. Abnormalities of the hepatobiliary system. In: Kirks DR, Griscom NT. Practical pediatric imaging: diagnostic radiology of infants and children. 3rded. Philadelphia, Pa: Lippincott- Raven, 1998. 954- 979.
[21]贾立群,王晓曼,曾津津,等.婴儿型肝脏血管内皮细胞瘤的影像诊断(附6例报告及文献复习) .中国临床医学影像杂志,2004, 15( 9) : 506- 508.
[22] Mehrabi A,Kashfi A,Schemmer P . Surgical treatment of primary hepatic epit helioid hema ngioe ndot helioma . Transplantation,2005,80:109 -112.
[23] SariN,Yalcin B, Akyuz C.Infantile hepatic hemangioendot helioma with elevated serum alpha- fetoprotein.Pediatr Hematol Oncol,2006,23:639 -647.
[24] Earnest F, Johnson D. Case 96: hepatic epithelioid hemangioendot helioma. Radiology, 2006,24:295 - 98.
[25] Mehrabi A,Kashfi A ,Fonouni H. Primary malignant hepatic epit helioid hemangioendot helioma:a comprehensive review of the literature with emphasis on the surgical therapy. Cancer,2006,107:2108– 2121.
[26] Goncalves-Matoso V,Renella R,Gudinc het F. Undifferentiated sarcoma of the liver: a rare tumor of childhood . Arch Pediatr,2005,12:1624– 1626.
[27] AhmetMesrur HalefoIlu.Magnetic resonance imaging of infantile hemangioendothelio- ma. The Turkish Journal of pediatrics.2007,49:77.
[28] NgWH, Ching AS, Chan KF.Clinics in diagnostic imaging.Infantile hepatos plenic haemangioendotheliomas . Singapore Medical Journal,2003,44: 491.
[29] MorteleK J, Vanzieleghem B, Mortele B. Solitary hepatic hemangioendothelioma: dyna- mic gadolinium - enhanced MR imaging findings.European Radiology. 2002, 12: 862.
[30]王建华,王小林,颜志平.腹部介入放射学[M].上海:上海医科大学出版社,1998: 73.
[31]段承祥,吕桃珍,陶文照,等.肝血管瘤CT表现的病理基础[J].中华放射学杂志, 1990, 24: 263.
[32] Hoe LV,Bert AL1 Gryspeedrdts. Dualphase helical CT of the liver :Value of an early phase acquisition in the differential diagnosis of noncystic focal lesions[J ].AJR , 1997 , 168 (5) :1185 -11861.
[33]邵广瑞.肝肿瘤的影像学诊断[ J ].中国中西医结合影像学杂志,2006,2(4):77-79.
[34]王成林,刘小平.肝脏肿瘤性囊性病变CT、MRI诊断[J ].中国CT和MR I杂志, 2004, 2(1): 52-55.
[35]杨业发,陈汉,吴孟超.肝海绵状血管瘤的诊断与治疗[J].腹部外科.2004,17(5):317-318.
[36] Hennan P,Mareelo LVC,MachadoMAC,et al.Management of HePatic Hemangiomas: A 14 Year ExPerienee.GSurgery.2005,9(6):853- 859.
[37] Hamaloglu E,Altun H,Ozdemir A.Giantliverhemangioma:therapy-by-enucleation or liver resection. WorldSurs,2005,29(7):590-591.
[38] Glinkova V,Shevah V,Boaz M. Hepatic hemangionmas:possible association with female sex homones. Gut,2004,53(9):1352- 1355.
[39] Li GW,Chen QL,Jiang JI. The origin of blood supply for cavemous of the liver. Hepato- bil Pancr Dis Int,2003,2(3):367.
[40]董江秋,胡大为,李桂平,等.肝血管瘤动脉造影治疗[J].临床肝胆杂志, 2004,20(4):248-250.
[41] Hartman DL,Gaither JM,Kesler KA.Comparison of insufflated talcunder tho- racoscopicand bleomycin pleurodesis for contral malignant pleural effasi ons. thorac cadiovascsurg, 1993,105 (4) : 743～748.
[42] KimHC,KimTK,SungKB.CT during hepatic arteriography and ortography: an illustrative review. Radiographics, 2002 ,22 :1041-1051.
[43]韦树长,王云华.平阳霉素用于肝血管瘤栓塞治疗的价值与限度[J].临床放射学杂志,2007,26(8):835.
[44] Thierry B,Patruce TI,Jean M. Hepatic intraarterial iodized oil for treatment of hepatoce- llular cancer in patiens with impeded portal venous flow. Radiology, 1999, 212(3): 665- 668.
[45]陈宏生.疏肝消积散治疗肝脏血管瘤21例[J].1993,14(2):53.
[2] Ishak KG, Robin L Benign tumors of the liver.Med Clinivorth Am, 1975,59(4):995-1013.
[3] Tulsyan N, Kashyap VS, Greenberg RK.The endovascular management of visceral artery aneurysns and pseudoaneurysms. Vasc, 2007, 45: 276-282.
[4] Trastek VF, Van Heerden JA, Sheedy PF.Cavernous hemangiomas of the liver:resect or observe.AmJ Surg, 1983, 145(1):49-53.
[5]马飞虹,王曼曼,朱光宇. 200例肝血管瘤的CT变现探索[J].黑龙江医药科学,2006, 29(6): 80.
[6]章其林.多层螺旋CT动脉期对肝海绵状血管瘤的诊断价值[J].淮海医药, 2009, 27(5): 398-399.
[7]王捷,孙德仁.组织CT值及电子相对密度的测定及结果分析[J].中华放射肿瘤学杂志,2004,13(4):307-308.
[8]邱双健,樊嘉,陈培.肝脏血管瘤的影像学诊断[J].肝胆外科杂志,2008, 16(6):497-411.
[9]朱斌.肝血管瘤放射介入治疗[J].肝胆外科杂志,2005, 14(2):93-95.
[10] Chen JH, Shen WC. Hyperdynamic hemangioma with proximal arterioportal shunting: a rare manifestation.Eur Radiol, 2003, 13: 1920.
[11]李兴胜,王世锦,谭戈辉.肝脏转移瘤的CT表现[J].临床肝胆病杂志,2006,22(4):265-266.
[12] Jang H,Kim TK, Lim HK. Hepatic Hemangioma:Atypical Appearances on CT, MR Ima-ging, and Sonography.AJR, 2003, 180(1): 135-141.
[13]曹丹庆,蔡祖龙.全身CT诊断学[M].北京:人民军医出版社, 1996:440.
[14] Jiang Lin, Yuan Ji. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma.Original Article liver, 2010, 9(2): 154-158.
[15]李斐,陈国新.肝脏肿瘤的超声诊断及鉴别诊断[J].中国实用医药,2010, 5(11):103-104.
[16] Mortele KJ, Vanzieleghem B, Mortele B. Solitary hepatic hemangioend othelioma: dyna- mic gadolinium-enhanced MR imaging findings. European Radiology. 2002, 12: 862.
[17] Mathieu D, Bruneton JN, Drouilard J.Hepatic Adenomas and Focal Nodular Hyperplasia:Dynamic CT Study.Radiology, 1986, 160(1): 53.
[18]王俭,刘光华,肖湘生,等.肝血管瘤的临床、病理再评价[J].实用放射性杂志,1999,15(2):99-100.
[19]荣增辉.肝血管瘤的CT诊断[J].现代医药卫生,2007, 23(7):1045-1046.
[20]俞滕先,郭宏伟,刘杰.多层螺旋CT对肝血管瘤的价值[J].重庆医学,2009,(38)13: 1635-1637.
[21]欧阳墉,王颖,欧阳雪辉,等.肝血管瘤供血和介入治疗的争议和探讨[J].中华放射学杂志,2004,38(7):746-750.
[22] Cynthia H. McCollough,PhD,Andrew N.Primak,PhD,Dose Performance of a 64-Channel Dual-Source CT Scanner.Radiology 2007,243:775-784.
[23] Kate Madden Yee, Multislice CT powers up with dual-source scanning. Special Report Trend in Radiology, 2007.
[24] Kim KW,Kim TK. Hepatic hemangiomas with arterioportal shunt : findings at twoph- ase CT. Radiology,2001,219 :707.
[25]李斐,陈国新.肝脏肿瘤的超声诊断及鉴别诊断[J].中国实用医药,2010,5(11):103-104.
[26]章其林.多层螺旋CT动脉期对肝海绵状血管瘤的诊断价值[J].淮海医药,2009, 27(5):398-399.
[27] Yamashita Y, ogata I, Urata J. Cavernous hemangioma of the liver:pathologic correlation with dynamic CT findings.Radiology, 1997, 203:121-125.
[28] MoriyasuH.Hepatic hemnagioma complicated with adenomyosis of the stomach:Primay right hepatic lobectomy and gaserectomy.Shujutsu,1962,16:1062.
[29]孙中杰,王国俊,潘承恩等.肝血管瘤的供血方式[J].第四军医大学学报,2002,23(6):576.
[30]赵仲蓉,李国威,王宝太,等.肝脏巨大海绵状血管瘤碘油栓塞治疗及其血供研究[J] .中华放射学杂志,1994,28 (7) : 472-474.
[31]杜锡林,马庆久,赵析山.等. B超引导下集束电极射频热毁损治疗肝脏海绵状血管瘤[J].中国实用外科杂志,2001,21(12):725-726.
[32]曾庆乐,李彦豪,陈勇,等.平阳霉素碘油乳剂治疗肝海绵状血管瘤的临床应用[J].介入放射学杂志,2000,34(7):456-458.
[1]叶继章.经导管注入平阳霉素碘化油乳剂栓塞肝血管瘤疗效分析[J].吉林医学,2010,31(30):5333.
[2]苏彬. [肝巨大血管瘤手术策略],杭州:浙江大学,2009.
[3]郭启勇,申宝忠.介入放射学[M].北京:人民卫生出版社.2008,50.
[4]崔新建,王兆欣,陈保伦,等.血管内介入改良Seldinger技术股动脉指间定位法的研究与临床应用[J].中国医学影像技术,2001,17(2):190-191.
[5]胡跃峰.[肝血管瘤动脉栓塞疗效及其供血的分析研究],太原:山西医科大学,2006.
[6] GaoKA. Analysis of the Cause of Lipiodol Incompletely Accumulated in Liver Can- cer after TACE.Chin J Med Imaging Technol,2003,19(7):918-919.
[7] W.K.Moon,B.I.Choni,etal.Iodized-oi1 retention within hepatic hemangio ma: Charact- eristics on iodizee-oil CT.Abdom Imaging 1996,(21):420-426.
[8]邓燕贤,漆剑频.经肝动脉平阳霉素乳剂介入治疗肝海绵状血管瘤[J].放射性实践,2004,19(4):280-282.
[9]曾庆乐,李彦豪,陈勇,等.平阳霉素碘油乳剂治疗肝海绵状血管瘤的临床应用[J].介入放射学杂志,2000,34(7):456-458。
[10]廖凯兵,孙仁荣,卢雅仁.肝脏巨大海绵状血管瘤的介入治疗(附20例分析)[J].医学影像学杂志,2003,13(5):318-320.
[11]仉凤,暴玉振,等.平阳霉素碘油剂栓塞子宫动脉致肺毒性反应一例[J].介入放射学杂志,2004,13(4):350.
[12] Yamashita Y,Ogata I,Urata J. Cavernous hemangioma of the liver : pathologic correlation with dynamic CT findings. Radiology,1997,203:121.
[13]曾庆乐,李彦豪,陈勇,等.肝海绵状血管瘤的动脉造影分析[J].临床放射性杂志,2009,28(5):688-691.
[14] Zeng QL, Li YH, Chen Y. Gigantic cavernous hemangioma of the liver treated byIntra-arterial embolization with pingyangmycin-lipiodol emulsion: a multicenter study. C- ardiovasc Intervent Radiol, 2004, 27 :481-485.
[15]孙华,董永安,王苏峰,等.肝血管瘤肝动脉栓塞的疗效评价[J].生物医学工程与临床,2005,9(1):25-27.
[16] Tulsyan N,Kashyap VS,Greenberg RK.The endovascular management of visceral artery aneurysns and pseudoaneurysms. Vasc,2007,45:276-282.
[1] Hapatake J, Horie A, Nagafuchi Y . Hyalinized hemangioma 0f the liver[J].Am J Gastro- entero1. 1992, 87 (2) : 234 - 236.
[2]罗雁,陆伟.肝血管瘤的诊断与治疗[J].医学综述,2006, 12 (4) : 416.
[3]李绍林,张雪林,韩慧霞,等.周围型胆管细胞癌临床病理与CT及MR诊断研究[J].放射学实践, 2005, 20 (6) : 500.
[4] Lee VT, Magnaye M, Tan HW, Thng CH, Ooi LL. Scler osing haemangioma mimicking hepatocellular carcinoma [J]. Singapore Med J , 2005 Mar, 46 (3) : 140 - 143.
[5]谢玉茹,全显跃.周围型肝内胆管细胞癌的MR诊断价值[J].放射学实践, 2006, 21 (8) : 797 - 800.
[6]古杰洪,莫蕾,王海林,等.肝硬化性血管瘤的CT诊断与误诊分析[J].实用医学杂志, 2006, 22 (3) : 351 - 353.
[8]万亚红,张光休,程可洛.肝硬化性血管瘤7例[J].江西医药,1999:102-103.
[9]Selby DM, Stocker JT, Waclawtw MA. Infantile hemangioendothelioma of the liver[J]. Hepatology,1994,20:39-45.
[10] Diment J, Yurim O, Pappo O. Infantile hemangioendothelioma of the liver in an adult. Arch Pathol Lab Med,2001,125:931-932.
[11]徐赛英.实用儿科放射诊断学[M].北京:北京出版社,1999.629-632.
[12] Kaniklides C, Dimopoulos PA, Bajic D. Infantile hemangioendothelioma.Acta Radiolog- ic,2000,41:161-164.
[13] Schweinitz DV Management of liver tumors in children.Seminars in pediatric Surgery, 2006,15(1):17-24.
[14]胡显良,何小兵.小儿肝脏肿瘤分析与介入治疗[J].广州医药,2001,32(5): 22-23.
[15] DallerJA ,Bueno GJ ,Dvorchik I. Hepatic Hemangioendot helioma:Clinical Experience and Management Strategy.Pediatr Surg,1994,34(1):98.
[16] Davenport M , Hansen L , Heaton ND. Hemangioendot helioma of t he Liver in Infants .J Pediat r Surg ,1995 ,30 (1) :44.
[17] Prokurat A , Klug P ,Chrupek M.Hemangioma of the liver in children : preliferating vas- cular tumor or congenital vascular malformation.Med Pediatr Oncol, 2002,39 :524 - 529.
[18] Prokurat A, Kluge P, Chrupek M. Hemangioma of the Liver in Children: Proliferating Vascular Tumor or Congenital Vascular Malformation Med Pediatr Oncol , 2002, 39( 5) : 524- 529.
[19] Kassarjian A, Zurakowski D, Dubois J. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR, 2004, 182( 3) : 785- 795.
[20] Buonomo C, Taylor GA, Share JC. Abnormalities of the hepatobiliary system. In: Kirks DR, Griscom NT. Practical pediatric imaging: diagnostic radiology of infants and children. 3rded. Philadelphia, Pa: Lippincott- Raven, 1998. 954- 979.
[21]贾立群,王晓曼,曾津津,等.婴儿型肝脏血管内皮细胞瘤的影像诊断(附6例报告及文献复习) .中国临床医学影像杂志,2004, 15( 9) : 506- 508.
[22] Mehrabi A,Kashfi A,Schemmer P . Surgical treatment of primary hepatic epit helioid hema ngioe ndot helioma . Transplantation,2005,80:109 -112.
[23] SariN,Yalcin B, Akyuz C.Infantile hepatic hemangioendot helioma with elevated serum alpha- fetoprotein.Pediatr Hematol Oncol,2006,23:639 -647.
[24] Earnest F, Johnson D. Case 96: hepatic epithelioid hemangioendot helioma. Radiology, 2006,24:295 - 98.
[25] Mehrabi A,Kashfi A ,Fonouni H. Primary malignant hepatic epit helioid hemangioendot helioma:a comprehensive review of the literature with emphasis on the surgical therapy. Cancer,2006,107:2108– 2121.
[26] Goncalves-Matoso V,Renella R,Gudinc het F. Undifferentiated sarcoma of the liver: a rare tumor of childhood . Arch Pediatr,2005,12:1624– 1626.
[27] AhmetMesrur HalefoIlu.Magnetic resonance imaging of infantile hemangioendothelio- ma. The Turkish Journal of pediatrics.2007,49:77.
[28] NgWH, Ching AS, Chan KF.Clinics in diagnostic imaging.Infantile hepatos plenic haemangioendotheliomas . Singapore Medical Journal,2003,44: 491.
[29] MorteleK J, Vanzieleghem B, Mortele B. Solitary hepatic hemangioendothelioma: dyna- mic gadolinium - enhanced MR imaging findings.European Radiology. 2002, 12: 862.
[30]王建华,王小林,颜志平.腹部介入放射学[M].上海:上海医科大学出版社,1998: 73.
[31]段承祥,吕桃珍,陶文照,等.肝血管瘤CT表现的病理基础[J].中华放射学杂志, 1990, 24: 263.
[32] Hoe LV,Bert AL1 Gryspeedrdts. Dualphase helical CT of the liver :Value of an early phase acquisition in the differential diagnosis of noncystic focal lesions[J ].AJR , 1997 , 168 (5) :1185 -11861.
[33]邵广瑞.肝肿瘤的影像学诊断[ J ].中国中西医结合影像学杂志,2006,2(4):77-79.
[34]王成林,刘小平.肝脏肿瘤性囊性病变CT、MRI诊断[J ].中国CT和MR I杂志, 2004, 2(1): 52-55.
[35]杨业发,陈汉,吴孟超.肝海绵状血管瘤的诊断与治疗[J].腹部外科.2004,17(5):317-318.
[36] Hennan P,Mareelo LVC,MachadoMAC,et al.Management of HePatic Hemangiomas: A 14 Year ExPerienee.GSurgery.2005,9(6):853- 859.
[37] Hamaloglu E,Altun H,Ozdemir A.Giantliverhemangioma:therapy-by-enucleation or liver resection. WorldSurs,2005,29(7):590-591.
[38] Glinkova V,Shevah V,Boaz M. Hepatic hemangionmas:possible association with female sex homones. Gut,2004,53(9):1352- 1355.
[39] Li GW,Chen QL,Jiang JI. The origin of blood supply for cavemous of the liver. Hepato- bil Pancr Dis Int,2003,2(3):367.
[40]董江秋,胡大为,李桂平,等.肝血管瘤动脉造影治疗[J].临床肝胆杂志, 2004,20(4):248-250.
[41] Hartman DL,Gaither JM,Kesler KA.Comparison of insufflated talcunder tho- racoscopicand bleomycin pleurodesis for contral malignant pleural effasi ons. thorac cadiovascsurg, 1993,105 (4) : 743～748.
[42] KimHC,KimTK,SungKB.CT during hepatic arteriography and ortography: an illustrative review. Radiographics, 2002 ,22 :1041-1051.
[43]韦树长,王云华.平阳霉素用于肝血管瘤栓塞治疗的价值与限度[J].临床放射学杂志,2007,26(8):835.
[44] Thierry B,Patruce TI,Jean M. Hepatic intraarterial iodized oil for treatment of hepatoce- llular cancer in patiens with impeded portal venous flow. Radiology, 1999, 212(3): 665- 668.
[45]陈宏生.疏肝消积散治疗肝脏血管瘤21例[J].1993,14(2):53.